What top creators are saying about Metro Biotech(PRIVATE)
A biotech firm developing pharmaceutical-grade NAD+ precursors.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Metro Biotech in the last 30 days yet.
Top creators covering Metro Biotech (PRIVATE)
The 1 sources with the most insights about Metro Biotech on Kazuha.
Latest insights about Metro Biotech (PRIVATE)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Tuesday, February 24, 2026
Running five clinical trials on MIB-626 (NMN) for conditions like Alzheimer's to move the substance from supplement to FDA-approved drug.
Tuesday, February 24, 2026
Running five clinical trials on MIB-626 (NMN) for conditions like Alzheimer's to move the substance from supplement to FDA-approved drug.
Discussed alongside Metro Biotech (PRIVATE)
Other assets that creators frequently mention in the same content as Metro Biotech.
Frequently asked
Which podcasters and creators cover Metro Biotech (PRIVATE) the most?
The most active sources covering Metro Biotech (PRIVATE) on Kazuha are PHD Ventures. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Metro Biotech (PRIVATE) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Metro Biotech (PRIVATE) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Metro Biotech (PRIVATE)?
Creators covering Metro Biotech (PRIVATE) most frequently also discuss PRIVATE, UBX, PRIVATE, BTC, PRIVATE. See the "Discussed alongside" section above for full asset pages.